C-19393 S2and H2, new carbapenem antibiotics IV. Inhibitory activity against β-lactamases

28Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

New carbapenem antibiotics, C-19393 S2and H2, have been found to be potent and broad-spectrum inhibitors of β-lactamases. Among 11 types of β-lactamases tested, those from Escherichia coli (plasmid-bearing), Klebsiella pneumoniae, Proteus vulgaris, Serratia marcescens and Bacteroicles fragilis were especially sensitive. They also inhibited cephalosporinases insensitive to clavulanic acid. The inhibition by C-19393 S2and H2was of progressive type, except for the inhibition of E. coli enzyme (plasmid-mediated type I) by C-19393 H2. The inhibition of E. coli β-lactamase by C-19393 S2was irreversible, while that by C-19393 H2 was reversible. © 1981, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Okonogi, K., Nozaki, Y., Imada, A., & Kuno, M. (1981). C-19393 S2and H2, new carbapenem antibiotics IV. Inhibitory activity against β-lactamases. Journal of Antibiotics, 34(2), 212–217. https://doi.org/10.7164/antibiotics.34.212

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free